4.7 Review

STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions

期刊

BIOMEDICINE & PHARMACOTHERAPY
卷 158, 期 -, 页码 -

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.114168

关键词

Prostate cancer; STAT3 signaling; Drug resistance; Metastasis; Tumor progression

向作者/读者索取更多资源

Prostate cancer is the most common malignancy in men, causing high death rates annually. Diagnosis of prostate cancer relies on biomarkers like the PSA test, and prognosis is usually poor. The cancer cells spread rapidly and metastasis is a major cause of death. Current therapies include chemotherapy, surgery, radiotherapy, and targeted therapy. The progression of prostate cancer cells involves factors like the STAT3 signaling pathway, which promotes malignant behavior, glycolysis, and drug resistance. Natural products and small molecules have been developed for targeting STAT3 signaling in prostate cancer therapy.
The categorization of cancers demonstrates that prostate cancer is the most common malignancy in men and it causes high death annually. Prostate cancer patients are diagnosed mainly via biomarkers such as PSA test and patients show poor prognosis. Prostate cancer cells rapidly diffuse into different parts of body and their metastasis is also a reason for death. Current therapies for prostate cancer patients include chemotherapy, surgery and radiotherapy as well as targeted therapy. The progression of prostate cancer cells is regulated by different factors that STAT3 signaling is among them. Growth factors and cytokines such as IL-6 can induce STAT3 signaling and it shows carcinogenic impact. Activation of STAT3 signaling occurs in prostate cancer and it promotes malignant behavior of tumor cells. Induction of STAT3 signaling increases glycolysis and proliferation of prostate cancer cells and prevents apoptosis. Furthermore, STAT3 signaling induces EMT mechanism in increasing cancer metastasis. Activation of STAT3 signaling stimulates drug resistance and the limitation of current works is lack of experiment related to role of STAT3 signaling in radio-resistance in prostate tumor. Calcitriol, capsazepine and beta-elemonic are among the compounds capable of targeting STAT3 signaling and its inhibition in prostate cancer therapy. In addition to natural products, small molecules targeting STAT3 signaling have been developed in prostate cancer therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据